Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Y Ma

Showing results (81-90 of 147) with videos related to

Pageof 15
Sort By:
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 15, 2023
Radiologic extranodal extension for nodal staging in nasopharyngeal carcinomaQi Yong H Ai, Ann D King, Hui Yuan, et al.
The Oncologist|May 27, 2018
Association Between Serum Folate Level and Toxicity of Capecitabine During Treatment for Colorectal CancerStephen L Chan, Anthony W H Chan, Frankie Mo, et al.
Journal of the National Cancer Institute|November 7, 2002
Plasma Epstein-Barr virus DNA and residual disease after radiotherapy for undifferentiated nasopharyngeal carcinomaAnthony T C Chan, Y M Dennis Lo, Benny Zee, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 15, 2011
Hemorrhagic complications in a phase II study of sunitinib in patients of nasopharyngeal carcinoma who has previously received high-dose radiationE P Hui, B B Y Ma, A D King, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 10, 2008
New utility of an old marker: serial alpha-fetoprotein measurement in predicting radiologic response and survival of patients with hepatocellular carcinoma undergoing systemic chemotherapyStephen L Chan, Frankie K F Mo, Philip J Johnson, et al.
Head & Neck|September 11, 2003
Prognostic significance of tumor angiogenesis, Ki 67, p53 oncoprotein, epidermal growth factor receptor and HER2 receptor protein expression in undifferentiated nasopharyngeal carcinoma--a prospective studyBrigette B Y Ma, Terence C W Poon, K F To, et al.
Investigational New Drugs|November 13, 2012
Preclinical evaluation of the AKT inhibitor MK-2206 in nasopharyngeal carcinoma cell linesBrigette B Y Ma, Vivian W Y Lui, Connie W C Hui, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 28, 2011
A phase II study of concurrent cetuximab-cisplatin and intensity-modulated radiotherapy in locoregionally advanced nasopharyngeal carcinomaB B Y Ma, M K M Kam, S F Leung, et al.
International Journal of Radiation Oncology, Biology, Physics|October 3, 2006
Relationship between pretreatment level of plasma Epstein-Barr virus DNA, tumor burden, and metabolic activity in advanced nasopharyngeal carcinomaBrigette B Y Ma, Ann King, Y M Dennis Lo, et al.
Clinical Biochemistry|September 21, 2007
The effect of centrifugation on circulating mRNA quantitation opens up a new scenario in expression profiling from patients with metastatic colorectal cancerS C Cesar Wong, Brigette B Y Ma, Paul B S Lai, et al.
Pageof 15

Showing results (81-90 of 147) with videos related to

Sort By:
Pageof 15
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 15, 2023
Radiologic extranodal extension for nodal staging in nasopharyngeal carcinomaQi Yong H Ai, Ann D King, Hui Yuan, et al.
The Oncologist|May 27, 2018
Association Between Serum Folate Level and Toxicity of Capecitabine During Treatment for Colorectal CancerStephen L Chan, Anthony W H Chan, Frankie Mo, et al.
Journal of the National Cancer Institute|November 7, 2002
Plasma Epstein-Barr virus DNA and residual disease after radiotherapy for undifferentiated nasopharyngeal carcinomaAnthony T C Chan, Y M Dennis Lo, Benny Zee, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 15, 2011
Hemorrhagic complications in a phase II study of sunitinib in patients of nasopharyngeal carcinoma who has previously received high-dose radiationE P Hui, B B Y Ma, A D King, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 10, 2008
New utility of an old marker: serial alpha-fetoprotein measurement in predicting radiologic response and survival of patients with hepatocellular carcinoma undergoing systemic chemotherapyStephen L Chan, Frankie K F Mo, Philip J Johnson, et al.
Head & Neck|September 11, 2003
Prognostic significance of tumor angiogenesis, Ki 67, p53 oncoprotein, epidermal growth factor receptor and HER2 receptor protein expression in undifferentiated nasopharyngeal carcinoma--a prospective studyBrigette B Y Ma, Terence C W Poon, K F To, et al.
Investigational New Drugs|November 13, 2012
Preclinical evaluation of the AKT inhibitor MK-2206 in nasopharyngeal carcinoma cell linesBrigette B Y Ma, Vivian W Y Lui, Connie W C Hui, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 28, 2011
A phase II study of concurrent cetuximab-cisplatin and intensity-modulated radiotherapy in locoregionally advanced nasopharyngeal carcinomaB B Y Ma, M K M Kam, S F Leung, et al.
International Journal of Radiation Oncology, Biology, Physics|October 3, 2006
Relationship between pretreatment level of plasma Epstein-Barr virus DNA, tumor burden, and metabolic activity in advanced nasopharyngeal carcinomaBrigette B Y Ma, Ann King, Y M Dennis Lo, et al.
Clinical Biochemistry|September 21, 2007
The effect of centrifugation on circulating mRNA quantitation opens up a new scenario in expression profiling from patients with metastatic colorectal cancerS C Cesar Wong, Brigette B Y Ma, Paul B S Lai, et al.
Pageof 15